(Q46890950)

26 December 2017

title

Chronic olanzapine treatment causes differential expression of genes in frontal cortex of rats as revealed by DNA microarray technique (English)

1 reference

26 December 2017

author

David Siderovski

9

1 reference

26 December 2017

author name string

S Hossein Fatemi

1

1 reference

26 December 2017

Teri J Reutiman

2

1 reference

26 December 2017

Timothy D Folsom

3

1 reference

26 December 2017

Christopher Bell

4

1 reference

26 December 2017

Lisa Nos

5

1 reference

26 December 2017

Peter Fried

6

1 reference

26 December 2017

David A Pearce

7

1 reference

26 December 2017

Sushmita Singh

8

1 reference

26 December 2017

Francis S Willard

10

1 reference

26 December 2017

Mitsunori Fukuda

11

1 reference

26 December 2017

language of work or name

English

0 references

publication date

11 January 2006

1 reference

26 December 2017

published in

Neuropsychopharmacology

1 reference

26 December 2017

volume

31

1 reference

26 December 2017

issue

9

1 reference

26 December 2017

page(s)

1888-1899

1 reference

26 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.npp.1301002

exact match

0 references

cites work

Assessing the validity of blood-based gene expression profiles for the classification of schizophrenia and bipolar disorder: a preliminary report

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

Effect of chronic olanzapine treatment on nerve growth factor and brain-derived neurotrophic factor in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Modulation of synaptic plasticity and memory by Reelin involves differential splicing of the lipoprotein receptor Apoer2

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Microarray analysis of differentially expressed genes in rat frontal cortex under chronic risperidone treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Differential display polymerase chain reaction reveals increased expression of striatal rat glia-derived nexin following chronic clozapine treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

cDNA array reveals differential gene expression following chronic neuroleptic administration: implications of synapsin II in haloperidol treatment.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

A genome-wide scan for linkage to chromosomal regions in 382 sibling pairs with schizophrenia or schizoaffective disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Impaired brain development and hydrocephalus in a line of transgenic mice with liver-specific expression of human insulin-like growth factor binding protein-1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Early changes in gene expression in two models of Batten disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Dysregulation of the fibroblast growth factor system in major depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Reelin glycoprotein: structure, biology and roles in health and disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Reduction in Reelin immunoreactivity in hippocampus of subjects with schizophrenia, bipolar disorder and major depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Altered levels of Reelin and its isoforms in schizophrenia and mood disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Prenatal viral infection in mouse causes differential expression of genes in brains of mouse progeny: a potential animal model for schizophrenia and autism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Reelin signaling is impaired in autism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Reduced blood levels of reelin as a vulnerability factor in pathophysiology of autistic disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

GABAergic dysfunction in schizophrenia and mood disorders as reflected by decreased levels of glutamic acid decarboxylase 65 and 67 kDa and Reelin proteins in cerebellum

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Dysregulation of Reelin and Bcl-2 proteins in autistic cerebellum

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Synaptotagmin IV: biochemistry, genetics, behavior, and possible links to human psychiatric disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

The X-linked mental retardation protein oligophrenin-1 is required for dendritic spine morphogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Regional distribution of regulators of G-protein signaling (RGS) 1, 2, 13, 14, 16, and GAIP messenger ribonucleic acids by in situ hybridization in rat brain.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Insulin-like growth factors, insulin resistance and schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Increased levels of serum basic fibroblast growth factor in schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Catalepsy as a rodent model for detecting antipsychotic drugs with extrapyramidal side effect liability

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Robust estimators for expression analysis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

CART peptides as targets for CNS drug development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Calbindin immunoreactivity in the hippocampal formation and neocortex of schizophrenics.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Effect of tranquilizers and antidepressants on glycogen phosphorylase of rat brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Exploration, normalization, and summaries of high density oligonucleotide array probe level data

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Glutamate as a therapeutic target in psychiatric disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Association between polymorphism in intron 1 of cocaine- and amphetamine-regulated transcript gene with alcoholism, but not with bipolar disorder and schizophrenia in Korean population

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

RGS2: a multifunctional regulator of G-protein signaling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Antipsychotic drug treatment induces differential gene expression in the rat cortex.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Effect of phenothiazines on the activity of glycogen phosphorylase b

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Differential effects of subchronic treatments with atypical antipsychotic drugs on dopamine D2 and serotonin 5-HT2A receptors in the rat brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Antipsychotic drug effects on brain morphology in first-episode psychosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Genomics and variation of ionotropic glutamate receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Antipsychotic drugs elevate mRNA levels of presynaptic proteins in the frontal cortex of the rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Differences in regional and subcellular localization of G(q/11) and RGS4 protein levels in Alzheimer's disease: correlation with muscarinic M1 receptor binding parameters

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Mutation screening of the Homer gene family and association analysis in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Fibroblast growth factor-2 is selectively modulated in the rat brain by E-5842, a preferential sigma-1 receptor ligand and putative atypical antipsychotic

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Immunocytochemical localization of glycogen phosphorylase isozymes in rat nervous tissues by using isozyme-specific antibodies.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Homer 1a gene expression modulation by antipsychotic drugs: involvement of the glutamate metabotropic system and effects of D-cycloserine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Selective modulation of fibroblast growth factor-2 expression in the rat brain by the atypical antipsychotic clozapine.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

A human gene encoding a putative basic helix-loop-helix phosphoprotein whose mRNA increases rapidly in cycloheximide-treated blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Evidence for linkage between regulatory enzymes in glycolysis and schizophrenia in a multiplex sample

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Long-term effects of olanzapine, risperidone, and quetiapine on ionotropic glutamate receptor types: implications for antipsychotic drug treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Striatal gene expression of RGS2 and RGS4 is specifically mediated by dopamine D1 and D2 receptors: clues for RGS2 and RGS4 functions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Antipsychotic drug treatment alters expression of mRNAs encoding lipid metabolism-related proteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Effects of acute and chronic administration of olanzapine in comparison to clozapine and haloperidol on extracellular recordings of substantia nigra reticulata neurons in the rat brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Altered expression of insulins I and II and their mRNAs in the islets of Langerhans in dexamethasone-induced diabetic rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Obesity and metabolic syndrome in circadian Clock mutant mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Liver pyruvate kinase polymorphisms are associated with type 2 diabetes in northern European Caucasians

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

A Model-Based Background Adjustment for Oligonucleotide Expression Arrays

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301002

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1301002

1 reference

26 December 2017

1 reference

26 December 2017